chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flank pain, Pulmonary embolism, Thrombophlebitis superficial, Ultrasound Doppler abnormal
Clinical narrative: MULTIPLE BILATERAL PULMONARY EMBOLI NONOCCLUSIVE RIGHT POPLITEAL DVT OCCLUSIVE RIGHT POSTERIOR TIBIAL VEIN AND RIGHT SMALL SAPHENEOUS VEIN THROMBOSIS  PATIENT BEGAN TO DEVELOP LEFT FLANK PAIN FOUR DAYS FOLLOWING VACCINATION FOLLOWED BY SEVERE SHORTNESS OF BREATH WITHIN THE FOLLOWING DAYS
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: The only issue i had was severe headache that lasted 4 days, nothing i took helped but now everything is great, so far
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: rash at injection point
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: no adverse event-- mixing error --diluent was used more than once to mix with covid vaccine
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Ultrasound scan
Clinical narrative: On 4/22 I felt two lymph nodes behind my left clavicle. Today is 4/26 and the lymph nodes felt larger so I saw the NP at the Drs Office and she gave me an order for an ultrasound of my neck if my lymph nodes don't go down in 10 days or if they get larger. The order states it is due to the assessment finding lymphadenopathy of left cervical region.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Started off with a small red rash at injection site hours after injection. The rash started to swell and increase in redness hours after that, and the next day the swelling and redness continued to increase. The swelling, redness, and pain continued to worsen over the next day until the welt reached about 3inches in height and 3inches across. The skin reaction formed a perfect circle around where I was injected. It has been around 78 hours and the welt is still very large, very red, very swollen, and very itchy. It also feels hot to the touch. No medicines have been able to assist with the swelling or pain, and cold compresses, ice, and heat also do not make the swelling or pain go down.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus
Clinical narrative: 8 days after I received the first dose of Moderna, I woke up and my arm at the injection site was swollen, painful to touch or lift my arm, tight, itchy and red.  The patch is about the size of my cupped hand over the mass.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Skin tightness
Clinical narrative: 8 days after I received the first dose of Moderna, I woke up and my arm at the injection site was swollen, painful to touch or lift my arm, tight, itchy and red.  The patch is about the size of my cupped hand over the mass.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: The Patient is a Marine Corps recruit and inadvertently received a second Covid-19 vaccine dose. This facility on administers the Moderna vaccine.   The Patient received his first Moderna vaccine dose here after being screened by our staff, but it was discovered that this was his second dose - the first dose being Pfizer and receiving that dose on 02 Feb 2021. The paperwork  was turned in after receiving the dose and the secondary screening  team then noticed the previous dose documented on the paperwork. Staff were notified and the Patient was monitored for 30 minutes, no adverse reaction was noted by the patient or the staff.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error --used multi diluent twice to draw and mix with covid vaccine
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Limb mass, Myalgia
Clinical narrative: 1-2inch solid mass grew in my left arm, near my armpit starting a day after the injection; otherwise only general Muscle soreness.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Herpes zoster, Neuralgia, Rash
Clinical narrative: I developed shingles after the 2nd shot- burning nerve pain on my torso and slight rash
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I?ve had pain in both legs off and on since the Janssen shot.  Had an issue with clots and blood supply in previous and recent pregnancies
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Loss of consciousness
Clinical narrative: Friday morning at 4:30am I woke up to go workout and as I was brushing my teeth I passed/blacked out. I came to and I began sweating profusely.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error--diluent was used twice from same multi vial to mix with covid vaccine
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Nausea, Pain, Pyrexia
Clinical narrative: 4/23/2021 2nd Dose of Moderna Shot. Symptoms started at 9pm. Fever, body aches, chills, loss of appetite and nausea.  4/24/2021 Symptoms felt worse in the morning but got better through the day.   Body felt better at night  4/25/2021 No symptoms and regained appetite.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Fibrin D dimer increased, Pain in extremity, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: posterior tibial vein non-occlusive thrombus. RLE pain starting 4/23, diagnosed 4/26
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error --used twice to punch diluent vial to mix with covid vaccine
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Bruising and swelling was gone after three days post-shot.  I woke up eight days post-shot and the injection site was red, itchy, and there was a lump the size of a small orange.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site induration
Clinical narrative: Immediate pain x 2 days that improved but Erythema and induration of area starting at Day 7 and worsening; seen in clinic on day 9 and area affected was 10 cm in diameter
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Episcleritis, Eye pain, Eye swelling, Ocular hyperaemia
Clinical narrative: I do not know if this diagnosis is due to covid vaccine or not, but wanted to check it out. 4/3/21 redness at left eye; Urgent Care described as pink eye; gave me polymyxin B-TMP eye drops 4/7/21 redness at left eye; Urgent Care again said pink eye and did negative covid test; prescribed Ciprofloxacin Ophthalmic  4/21/21 Went to Opthamology Associates because still red/pink.  diagnosed as Episcleritis of left eye and prescribed Alrex 0.2% eye drops 4/23/21 called Opthamology Associates because now left eye lid sore and swollen.  told me to continue with drops and keep upcoming appointment on 4/29/21 and call if emergency occurs before then. and use hot compresses.   As of today, may be a little better.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmological examination
Clinical narrative: I do not know if this diagnosis is due to covid vaccine or not, but wanted to check it out. 4/3/21 redness at left eye; Urgent Care described as pink eye; gave me polymyxin B-TMP eye drops 4/7/21 redness at left eye; Urgent Care again said pink eye and did negative covid test; prescribed Ciprofloxacin Ophthalmic  4/21/21 Went to Opthamology Associates because still red/pink.  diagnosed as Episcleritis of left eye and prescribed Alrex 0.2% eye drops 4/23/21 called Opthamology Associates because now left eye lid sore and swollen.  told me to continue with drops and keep upcoming appointment on 4/29/21 and call if emergency occurs before then. and use hot compresses.   As of today, may be a little better.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenitis, Lymphadenopathy, Pyrexia
Clinical narrative: Fever, chills, swollen lymph nodes in neck and shoulder on injection side.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac, Chest pain, Computerised tomogram thorax, Dizziness, Dyspnoea
Clinical narrative: Severe Myocarditis, radiating chest pain, difficulty breathing, dizziness
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis, Troponin
Clinical narrative: Severe Myocarditis, radiating chest pain, difficulty breathing, dizziness
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Polymenorrhoea, Tinnitus, Vertigo
Clinical narrative: Early menstrual cycle by one week, slight vertigo, buzzing in right ear, intense headache
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: Severe pain in left shoulder joint when lifting arm above head and/or elbow to shoulder height.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Injection site rash, Muscle spasms
Clinical narrative: After the first dose (end of March), I had a large red rash at the injection site which lasted almost two weeks.  After my second dose (April 20), I had an intense reaction. I was up most of the night freezing cold, leg hair standing on end, and body aching. Had to take a hot shower to cope with the chills. I finally fell asleep for two hours and woke up in hot sweats and an intense headache. I was fine by the afternoon, but developed a new and unusual symptom around 1pm -- sharp localized pains that would intermittently shoot through random parts of my body (mostly legs, but also arms and midsection). They were so bad I would keel over while standing and gasp. Each day since, they have lessened in intensity, but are still somewhat present (it is 11pm on April 26, one week later). Now, I have what I would describe as subtle, localized cramps (?) in random areas (calves, thigh, tricep, back) that come and go -- more of an ache-y sensation but widespread across my body. It is nothing I have experienced before, and only started after the vaccination.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain
Clinical narrative: After the first dose (end of March), I had a large red rash at the injection site which lasted almost two weeks.  After my second dose (April 20), I had an intense reaction. I was up most of the night freezing cold, leg hair standing on end, and body aching. Had to take a hot shower to cope with the chills. I finally fell asleep for two hours and woke up in hot sweats and an intense headache. I was fine by the afternoon, but developed a new and unusual symptom around 1pm -- sharp localized pains that would intermittently shoot through random parts of my body (mostly legs, but also arms and midsection). They were so bad I would keel over while standing and gasp. Each day since, they have lessened in intensity, but are still somewhat present (it is 11pm on April 26, one week later). Now, I have what I would describe as subtle, localized cramps (?) in random areas (calves, thigh, tricep, back) that come and go -- more of an ache-y sensation but widespread across my body. It is nothing I have experienced before, and only started after the vaccination.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error --used twice to puncture diluent to draw and mix with covid vaccine
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous, Rash pruritic
Clinical narrative: Large red itchy round rash at vaccination site 7 days after getting the first shot
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Redness, itching and swelling worsening over time. Redness getting larger.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia, Vomiting
Clinical narrative: ??Headache ~ 4/23/21 @ 1:30 p.m. through 4/25/21 @ 5 p.m. ??Nausea ~ 4/23/21 @ 2 p.m. through 4/25/21 @ 9 p.m. ??Vomitting ~ 4/24/21 @ 10 a.m.  ?? Fever ~ 4/24/21 @ 8:30 a.m. 99.6
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bell's Palsy
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Urticaria
Clinical narrative: Experienced chills, feverish, headache, body aches less than 24 hours after injection. Around 36 hours later broke out in sever hives rash. Hives keep improving and then getting worse again hours later even after Benadryl, steroid shot and Zyrtec
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error--used more than once to draw diluent from multi dose vial to mix with covid vaccine
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Experienced chills and fever starting shortly after the 24 hour mark after the vaccine and lasting roughly 8 to 10 hours.  Fatigue and severe headache starting around the 24 hour mark and continuing until the 72 hour mark.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: I have been without a menstrual cycle for a minimum of 2 years because of the Depo Provera injections.  However, I had vaginal spotting/light bleeding  that started approximately 9 hours after I received the vaccine and lasted for about 48 hours.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Neck pain, Pain in extremity
Clinical narrative: Severe headache, foggy feeling - strange. Excruciating pain at injection site - whole arm was so very painful. Radiated into shoulder and neck, down arm. Headache is so bad.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: mixing error-used twice to draw diluent from multi vial diluent to mix with covid vaccine
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pyrexia
Clinical narrative: Fever, chills, muscle aches, joint pain
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Tinnitus
Clinical narrative: Severe tinnitus and dizziness.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine (Pfizer Covid 19) was given to the patient who is 15 years and 5 months (under 16). The vaccine was given by a national guard. Nurse called and talked to his mom the next day, and she said she thought the vaccine got approval from 12 years old and up. There was no adverse reactions.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Varicella virus test positive
Clinical narrative: Shingles; symptoms began on 4/13, test swab taken on 4/19, and positive results returned on 4/23. Completed 7-day course of Valtrex and symptoms currently on the mend.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Atrial flutter, Axillary pain, Fatigue
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypertension, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Memory impairment, Nausea, Peripheral swelling
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Atrial flutter, Axillary pain, Blood pressure measurement, Fatigue
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypertension, Memory impairment, Nausea, Pain in extremity
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rash, Swelling, Vaccination site pain
Clinical narrative: 1-5 days swelling and rash, pain in arm at injection side Day 3-4 Throbbing leg - felt artery flutter. 1-12 days recurring headache 3-18 days pain in shoulder and armpit near injection site Day 12-18 swelling in hand Day 2-18 - extreme fatigue, lack of energy Day 2-18 - higher blood pressure Day 4-18 ? Nausea and forgetfulness
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: None stated.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Hot flush, Nausea
Clinical narrative: Severe and sudden vertigo, nausea, and dissyness. Rotating between hot flashes and chills, unable to keep food/water down.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Severe and sudden vertigo, nausea, and dissyness. Rotating between hot flashes and chills, unable to keep food/water down.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Myalgia
Clinical narrative: About 10 days past vaccination I started to experience a muscle burning sensation when lifting my arm causing quite discomfort. It?s a muscle pain that is limiting the range of motion, coming from my upper arm (below shoulder facing outwards) and traveling down in my entire arm when I am lifting my arm. I didn?t pay attention to it as I thought I just pulled a muscle. Meanwhile the pain is still present and it seems to be getting worse. There is also a certain degree of hotness to the skin when touched by the injection site.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Burning sensation, Chills, Fatigue, Headache
Clinical narrative: Fever, chills, shakes, burning sensation, body and backache, headache day of vaccine. Migraine day 2. Muscle pain x 10 days. Fatigue Day of vaccine x7 days. Alteration of smell day of vaccine to current date.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain, Parosmia, Pyrexia, Tremor
Clinical narrative: Fever, chills, shakes, burning sensation, body and backache, headache day of vaccine. Migraine day 2. Muscle pain x 10 days. Fatigue Day of vaccine x7 days. Alteration of smell day of vaccine to current date.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: RED, ITCHY, WARM TO THE TOUCH , SWOLLEN. LASTED A FEW DAYS.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Tinnitus
Clinical narrative: Tinnitus, High pitched frequency primarily in left ear.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Rash macular
Clinical narrative: About a week after receiving the vaccine, a sudden red splotch has appeared around the injection site. Red splotch is warm to the touch and tender.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine given to a patient below the age of 18.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Pain near injection site.  Pain has continued since my first injection.  I continue to have trouble getting dressed and many other simple tasks.  I had no adverse symptoms from my second injection.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: transient, daily low grade occipito-temporal headache
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Pulmonary congestion
Clinical narrative: Chest congestion, weight in center of chest, little coughing, breathing ok Pfizer-BioNTech COVID-19 Vaccine EUA
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Beginning of menstruation after not having menstruated since October 2020.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Computerised tomogram head abnormal, Deep vein thrombosis, Dizziness, Dyspnoea
Clinical narrative: Patient had a syncopal episode while on the toilet and moving her bowels on night of 4/15. She struck head and sustained left peri-orbital laceration.  Was seen at ER on 4/16. Had CT of head showing cutaneous injury only. Was discharged home.  On 4/20 she first noted swelling in right calf. This worsened and was seen in Care Center on 4/23. Had high D-dimer and had ultrasound of leg at ER. This showed right leg DVT extending from the distal femoral vein through the popliteal and posterior tibial veins. She had a long wait and left. She called PCP's on 4/24 on was prescribed Eliquis. She had trouble getting prescription filled due to cost and need for insurance pre-approval. Finally picked up and started Eliquis on the morning of 4/25. She contacted PCP's office on morning of 4/26 with new complaint of "terrible shortness of breath and lightheadedness". Patient was seen. CTA of chest done at hospital. showed "a large bilateral acute bilateral pulmonary embolism with saddle embolus, involving the right and left main pulmonary arteries, as well as the lateral lower lobe, upper lobe, right middle lobe, and lingular segmental and subsegmental branches. There is slight bowing of the interatrial ventricular septum to the left consistent with right heart strain." Patient to be admitted for thrombectomy
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Head injury, Myocardial strain, Peripheral swelling, Pulmonary embolism
Clinical narrative: Patient had a syncopal episode while on the toilet and moving her bowels on night of 4/15. She struck head and sustained left peri-orbital laceration.  Was seen at ER on 4/16. Had CT of head showing cutaneous injury only. Was discharged home.  On 4/20 she first noted swelling in right calf. This worsened and was seen in Care Center on 4/23. Had high D-dimer and had ultrasound of leg at ER. This showed right leg DVT extending from the distal femoral vein through the popliteal and posterior tibial veins. She had a long wait and left. She called PCP's on 4/24 on was prescribed Eliquis. She had trouble getting prescription filled due to cost and need for insurance pre-approval. Finally picked up and started Eliquis on the morning of 4/25. She contacted PCP's office on morning of 4/26 with new complaint of "terrible shortness of breath and lightheadedness". Patient was seen. CTA of chest done at hospital. showed "a large bilateral acute bilateral pulmonary embolism with saddle embolus, involving the right and left main pulmonary arteries, as well as the lateral lower lobe, upper lobe, right middle lobe, and lingular segmental and subsegmental branches. There is slight bowing of the interatrial ventricular septum to the left consistent with right heart strain." Patient to be admitted for thrombectomy
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin laceration, Syncope, Ultrasound Doppler abnormal, Ventricular septal defect
Clinical narrative: Patient had a syncopal episode while on the toilet and moving her bowels on night of 4/15. She struck head and sustained left peri-orbital laceration.  Was seen at ER on 4/16. Had CT of head showing cutaneous injury only. Was discharged home.  On 4/20 she first noted swelling in right calf. This worsened and was seen in Care Center on 4/23. Had high D-dimer and had ultrasound of leg at ER. This showed right leg DVT extending from the distal femoral vein through the popliteal and posterior tibial veins. She had a long wait and left. She called PCP's on 4/24 on was prescribed Eliquis. She had trouble getting prescription filled due to cost and need for insurance pre-approval. Finally picked up and started Eliquis on the morning of 4/25. She contacted PCP's office on morning of 4/26 with new complaint of "terrible shortness of breath and lightheadedness". Patient was seen. CTA of chest done at hospital. showed "a large bilateral acute bilateral pulmonary embolism with saddle embolus, involving the right and left main pulmonary arteries, as well as the lateral lower lobe, upper lobe, right middle lobe, and lingular segmental and subsegmental branches. There is slight bowing of the interatrial ventricular septum to the left consistent with right heart strain." Patient to be admitted for thrombectomy
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis
Clinical narrative: Patient had a syncopal episode while on the toilet and moving her bowels on night of 4/15. She struck head and sustained left peri-orbital laceration.  Was seen at ER on 4/16. Had CT of head showing cutaneous injury only. Was discharged home.  On 4/20 she first noted swelling in right calf. This worsened and was seen in Care Center on 4/23. Had high D-dimer and had ultrasound of leg at ER. This showed right leg DVT extending from the distal femoral vein through the popliteal and posterior tibial veins. She had a long wait and left. She called PCP's on 4/24 on was prescribed Eliquis. She had trouble getting prescription filled due to cost and need for insurance pre-approval. Finally picked up and started Eliquis on the morning of 4/25. She contacted PCP's office on morning of 4/26 with new complaint of "terrible shortness of breath and lightheadedness". Patient was seen. CTA of chest done at hospital. showed "a large bilateral acute bilateral pulmonary embolism with saddle embolus, involving the right and left main pulmonary arteries, as well as the lateral lower lobe, upper lobe, right middle lobe, and lingular segmental and subsegmental branches. There is slight bowing of the interatrial ventricular septum to the left consistent with right heart strain." Patient to be admitted for thrombectomy
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: VACCINATOR OVERLOOKED PATIENT AGE AND MISTAKENLY ADMINISTERED MODERNA TO 16YO PATIENT
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT ADMINSTERED CORRECT VACCINE. PHARMACY PROCESSED PFIZER TO INSURANCE INSTEAD OF MODERNA
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: 48 hours before my Covid vac, I received my first dose of a Singles vac on March 19, 2021.     I received my first Covid vac on March 21, 2021 and within a couple of days i began to develop a fairly serious BRAIN FOG.   It was difficult to concentrate and make decisions.   This lasted for about 2-3 weeks.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine is for 18 and older she is 16.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram, Haemoptysis, Headache, Laboratory test
Clinical narrative: vomiting, blackout, fever, chills, muscle aches, coughing up blood, rash, sore throat, headache
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Myalgia, Oropharyngeal pain, Pyrexia, Rash
Clinical narrative: vomiting, blackout, fever, chills, muscle aches, coughing up blood, rash, sore throat, headache
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting, blackout, fever, chills, muscle aches, coughing up blood, rash, sore throat, headache
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Herpes zoster, Pain, Rash, Wound secretion
Clinical narrative: Shingles. A rash with oozing blisters still hurting and open 10 days after dose II I read about the Israeli study and I don't think it's a coincidence. I have never suffered from this before.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Herpes zoster
Clinical narrative: Shingles. A rash with oozing blisters still hurting and open 10 days after dose II I read about the Israeli study and I don't think it's a coincidence. I have never suffered from this before.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Glossodynia, Lymph node pain, Oropharyngeal pain, Tinnitus
Clinical narrative: 6 days after 2nd vaccine:  1. Tinnitus - left ear.  No treatment.  Disappeared after 12 hours. 2. Sore tongue, lymph nodes, throat. Gradually subsided after 4 days.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Patient fainted after getting the vaccine. She does have a HX of fainting when seeing needles. Water was given and BP was taken (was low 98/62)
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Severe headache, fever, chills, fatigue, whole body aches lasted about 24 to 36 hours
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Nausea, Pain
Clinical narrative: Vomiting once 5 hrs after shot Nausea ongoing 48 hrs Fever 100.7 ongoing for 24 hrs Severe headache ongoing for 24 hrs Body aches ongoing for 24 hrs Fatigue ongoing for 24 hrs Pain at injection site ongoing for 72 hrs Took 2 Tylenol every 6-8 hours for 24 hrs
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Vomiting once 5 hrs after shot Nausea ongoing 48 hrs Fever 100.7 ongoing for 24 hrs Severe headache ongoing for 24 hrs Body aches ongoing for 24 hrs Fatigue ongoing for 24 hrs Pain at injection site ongoing for 72 hrs Took 2 Tylenol every 6-8 hours for 24 hrs
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Heart rate increased, Hypertension
Clinical narrative: My heart went into AFIB from 7:30-9:30. I had to go to the ER and now am on blood pressure medicine. I am 29. This has never happened before.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain, Peripheral swelling, Pruritus
Clinical narrative: Very achy fever. Arm swollen red  burning and itchy as of today.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Very achy fever. Arm swollen red  burning and itchy as of today.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Impaired work ability, Influenza like illness, Nausea, Tremor
Clinical narrative: On day 5, severe nausea and repeated vomiting, lots of bile, became super hot, then freezing cold, shaking. Had to leave work. Flu like symptoms with really bad vomiting. At home resting. Might go to hospital.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: On day 5, severe nausea and repeated vomiting, lots of bile, became super hot, then freezing cold, shaking. Had to leave work. Flu like symptoms with really bad vomiting. At home resting. Might go to hospital.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lip pruritus, Lip swelling, Oral discomfort, Urticaria
Clinical narrative: On April 1, 2021, Upon arriving home from the vaccine shot (within two hours of the shot) I changed my clothes and noticed hives across my chest and down the front of my stomach. I immediately took a benadryl and they were gone the next morning. On April 24, I again had hives this time up my back and throughout my left arm. I didn't take a benadryl right away and then my lips started to itch/burn and get swollen. I took a benadryl and again the symptoms were gone in the morning. That was Saturday 4/24/21 it is now Monday 4/26/21, and I have not been feeling too well.    Prior to the vaccine, I have never had hives on my body.  Since getting the shot on April 1, 2021, I have broken out twice. Once immediately after, and again 3 weeks later.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Moderate pain in the left arm. First injection was in the left arm and the second was in the right arm.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain in extremity, Peripheral swelling, Pruritus, Rash
Clinical narrative: Painful arm with rash that is also hot, swollen, and itchy. Painful exactly one week after injection, then more of a rash appeared on day 8. Spread a bit down my arm on day 9, which is the day I am reporting.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Painful arm with rash that is also hot, swollen, and itchy. Painful exactly one week after injection, then more of a rash appeared on day 8. Spread a bit down my arm on day 9, which is the day I am reporting.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time normal, Anticoagulant therapy, Bacterial test, Blood bicarbonate increased, Blood creatinine increased
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, Blood lactic acid, Blood magnesium normal, Blood pH decreased, Blood phosphorus normal
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature decreased, Chest X-ray normal, Chest pain, Differential white blood cell count, Dyspnoea
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Fibrin D dimer, Glomerular filtration rate, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza A virus test, Influenza B virus test, Intensive care, Lipase normal, Mean cell volume normal
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, N-terminal prohormone brain natriuretic peptide increased, PCO2 increased, Platelet count normal, Prothrombin time prolonged
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, Red blood cell count decreased, Red cell distribution width normal, SARS-CoV-2 test negative, Troponin
Clinical narrative: 88 y.o. male with medical history of hypertension, dyslipidemia, sinus bradycardia, COPD ,OSA on CPAP night and AFib on Xarelto. Patient presented to the emergency room with a complaint of chest pain and worsening shortness of breath.Initial vitals in the ED showed temperature 36.1° heart rate 83 respiratory rate 20 blood pressure 150/89 SpO2 96%. CBC within normal, PT 18.8 APTT 39 D-dimer 1111, CMP showed bicarb 32 creatinine 1.39 E GFR 45 and lipase 146. Initial troponin is 53 with indeterminate to our delta, will follow-up on 6 hour delta. ProBNP 1663 with no baseline available. Patient tested negative for COVID-19. VBG showed pH 7.33 and pCO2 of 61 no baseline pCO2 available. Chest x-ray as per report no acute abnormality, personal impression increase interstitial reticular opacities suspicion of fluid overload/pulmonary edema. CT PE as per report filling defect left descending pulmonary artery consistent with acute pulmonary embolus. Patient admitted to the ICU for further monitoring and evaluation.     Patient started on heparin drip, rivaroxaban factor Xa antibody sent, as per patient he was compliant with Xarelto. Vascular medicine consult done recommended to bridge with warfarin versus start Lovenox. Discussed with the patient, patient prefers warfarin. Patient was started on warfarin INR 2-3. Resumed CPAP for OSA. Venous Doppler lower extremities negative for acute DVT. TTE showed Normal left ventricular chamber size. Estimated LV ejection fraction range 55-60%. No regional wall motion abnormalities. Mildly enlarged right ventricular chamber size and mildly reduced RV systolic function. Estimated RV systolic pressure 46 mm Hg. Moderately enlarged inferior vena cava size with reduced inspiratory collapse (<50%). No hemodynamically significant valvular heart disease. Patient was started on Lasix IV; converted to oral upon discharge. Patient discharged on Lovenox and warfarin. Patient medical condition improved with medical treatment